Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Ganini

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Expert Opinion on Biological Therapy|November 1, 2024
The future of cellular therapy for the treatment of renal cell carcinomaNada Chaoul, Eleonora Lauricella, Andrea Giglio, et al.
Biochemical and Biophysical Research Communications|April 17, 2022
p63 in corneal and epidermal differentiationFlavia Novelli, Carlo Ganini, Gerry Melino, et al.
Immunotherapy|July 9, 2024
Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinationsMimma Rizzo, Gaetano Pezzicoli, Carlo Ganini, et al.
Rare Tumors|October 23, 2012
Lingual metastasis from renal cell carcinoma: a case report and literature reviewCarlo Ganini, Angioletta Lasagna, Elisa Ferraris, et al.
Oncology|November 17, 2012
Changes in circulating pro-angiogenic cytokines, other than VEGF, before progression to sunitinib therapy in advanced renal cell carcinoma patientsCamillo Porta, Chiara Paglino, Ilaria Imarisio, et al.
Biology Direct|November 10, 2023
p63 orchestrates serine and one carbon metabolism enzymes expression in head and neck cancerAngela Cappello, Giulia Tosetti, Artem Smirnov, et al.
Journal of Endocrinological Investigation|November 10, 2025
Risk factors for endocrinological immune-related adverse events in patients with renal cell carcinoma treated with immune checkpoint inhibitorsNicola Marrano, Mariangela Caporusso, Carlo Ganini, et al.
International Journal of Molecular Sciences|June 10, 2022
No Time to Die: How Kidney Cancer Evades Cell DeathCarlo Ganini, Manuela Montanaro, Manuel Scimeca, et al.
BMC Urology|February 13, 2022
The efficacy of a suppository based on Phenolmicin P3 and Bosexil (Mictalase®) in control of irritative symptoms in patients undergoing thulium laser enucleation of prostate: a single-center, randomized, controlled, open label, phase III studyRiccardo Bertolo, Chiara Cipriani, Matteo Vittori, et al.
Oncology Research|May 1, 2026
The Real-World Endocrine Toxicity Profile of ICIs, VEGFR-TKIs, and Their Combination: Analysis of the FDA Adverse Event Reporting System (FAERS) DatabaseNicola Marrano, Mariangela Caporusso, Cosimo Matino, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Expert Opinion on Biological Therapy|November 1, 2024
The future of cellular therapy for the treatment of renal cell carcinomaNada Chaoul, Eleonora Lauricella, Andrea Giglio, et al.
Biochemical and Biophysical Research Communications|April 17, 2022
p63 in corneal and epidermal differentiationFlavia Novelli, Carlo Ganini, Gerry Melino, et al.
Immunotherapy|July 9, 2024
Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinationsMimma Rizzo, Gaetano Pezzicoli, Carlo Ganini, et al.
Rare Tumors|October 23, 2012
Lingual metastasis from renal cell carcinoma: a case report and literature reviewCarlo Ganini, Angioletta Lasagna, Elisa Ferraris, et al.
Oncology|November 17, 2012
Changes in circulating pro-angiogenic cytokines, other than VEGF, before progression to sunitinib therapy in advanced renal cell carcinoma patientsCamillo Porta, Chiara Paglino, Ilaria Imarisio, et al.
Biology Direct|November 10, 2023
p63 orchestrates serine and one carbon metabolism enzymes expression in head and neck cancerAngela Cappello, Giulia Tosetti, Artem Smirnov, et al.
Journal of Endocrinological Investigation|November 10, 2025
Risk factors for endocrinological immune-related adverse events in patients with renal cell carcinoma treated with immune checkpoint inhibitorsNicola Marrano, Mariangela Caporusso, Carlo Ganini, et al.
International Journal of Molecular Sciences|June 10, 2022
No Time to Die: How Kidney Cancer Evades Cell DeathCarlo Ganini, Manuela Montanaro, Manuel Scimeca, et al.
BMC Urology|February 13, 2022
The efficacy of a suppository based on Phenolmicin P3 and Bosexil (Mictalase®) in control of irritative symptoms in patients undergoing thulium laser enucleation of prostate: a single-center, randomized, controlled, open label, phase III studyRiccardo Bertolo, Chiara Cipriani, Matteo Vittori, et al.
Oncology Research|May 1, 2026
The Real-World Endocrine Toxicity Profile of ICIs, VEGFR-TKIs, and Their Combination: Analysis of the FDA Adverse Event Reporting System (FAERS) DatabaseNicola Marrano, Mariangela Caporusso, Cosimo Matino, et al.
Pageof 3